Collegium Pharmaceutical Inc
NASDAQ:COLL

Watchlist Manager
Collegium Pharmaceutical Inc Logo
Collegium Pharmaceutical Inc
NASDAQ:COLL
Watchlist
Price: 38.77 USD -0.87% Market Closed
Market Cap: 1.2B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+17%
Revenue
Forecast
+5%
Operating Income
Forecast
+14%
Net Income
Forecast
+50%

Wall Street
Price Targets

COLL Price Targets Summary
Collegium Pharmaceutical Inc

Wall Street analysts forecast COLL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COLL is 45.49 USD with a low forecast of 40.4 USD and a high forecast of 50.4 USD.

COLL Lowest Forecast
Wall Street Target
40.4 USD
4% Upside
COLL Average Forecast
Wall Street Target
45.49 USD
17% Upside
COLL Highest Forecast
Wall Street Target
50.4 USD
30% Upside
Lowest
Price Target
40.4 USD
4% Upside
Average
Price Target
45.49 USD
17% Upside
Highest
Price Target
50.4 USD
30% Upside
Collegium Pharmaceutical Inc Competitors:
Price Targets
INDOCO
Indoco Remedies Ltd
1% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
29% Upside
4506
Sumitomo Pharma Co Ltd
32% Downside
Z
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
14% Upside
INDOCO
Indoco Remedies Ltd
1% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
29% Upside
4506
Sumitomo Pharma Co Ltd
32% Downside
Z
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
14% Upside
688321
Shenzhen Chipscreen Biosciences Co Ltd
0% Downside
K
4521
Kaken Pharmaceutical Co Ltd
20% Upside
KALA
Kala Pharmaceuticals Inc
39% Upside
ROG
Roche Holding AG
17% Upside

Revenue
Forecast

Revenue Estimate
Collegium Pharmaceutical Inc

The compound annual growth rate of Collegium Pharmaceutical Inc's revenue for the next 3 years is 5%.

N/A
Past Growth
5%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Collegium Pharmaceutical Inc

The compound annual growth rate of Collegium Pharmaceutical Inc's operating income for the next 3 years is 14%.

N/A
Past Growth
14%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Collegium Pharmaceutical Inc

The compound annual growth rate of Collegium Pharmaceutical Inc's net income for the next 3 years is 50%.

N/A
Past Growth
50%
Estimated Growth
Estimates Accuracy
-27%
Average Miss
What are analyst estimates?

See Also

Summary
COLL intrinsic value, competitors valuation, and company profile.
DCF Valuation
COLL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
COLL stock valuation using valuation multiples.
Wall Street Estimates
COLL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
COLL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is COLL's stock price target?
Price Target
45.49 USD

According to Wall Street analysts, the average 1-year price target for COLL is 45.49 USD with a low forecast of 40.4 USD and a high forecast of 50.4 USD.

What is Collegium Pharmaceutical Inc's Revenue forecast?
Projected CAGR
5%

The compound annual growth rate of Collegium Pharmaceutical Inc's revenue for the next 3 years is 5%.

What is Collegium Pharmaceutical Inc's Operating Income forecast?
Projected CAGR
14%

The compound annual growth rate of Collegium Pharmaceutical Inc's operating income for the next 3 years is 14%.

What is Collegium Pharmaceutical Inc's Net Income forecast?
Projected CAGR
50%

The compound annual growth rate of Collegium Pharmaceutical Inc's net income for the next 3 years is 50%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 277,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.